DV Business Summary

DV Biomed Co., Ltd. (6539.TWO) is a Taiwan-based biotechnology firm specializing in the development, manufacturing, and retail of medical-grade skincare, functional health supplements, and aesthetic medical equipment. The company generates revenue through three primary business segments: the sale of proprietary skincare and beauty products under the "DV" brand, the provision of professional health and slimming services through a network of beauty salons, and the distribution of medical aesthetic fillers and high-intensity focused ultrasound (HIFU) devices. DV Biomed differentiates itself through its proprietary stem cell ingredient technology and a vertically integrated model that spans from R&D to direct-to-consumer service channels in Taiwan and China. In the competitive landscape, the company contends with major players such as DR.Wu Skincare (6523.TWO), Li Kang Biomedical (6242.TWO), and Shiny Brands Group (6775.TW), positioning itself as a niche provider of high-margin aesthetic solutions and wellness supplements. Founded in 2011, DV Biomed is led by Chairman and CEO Liqi Zhang, who has been instrumental in pivoting the company toward the high-growth medical aesthetic sector. The core leadership team includes Chief Financial Officer Huang Qing Jun and Chief Operating Officer Li Yi Yun, both of whom bring extensive experience in financial management and biomedical operations within the Taiwanese market. A defining feature of the company’s corporate structure is its strategic relationship with Collins Co., Ltd. (2906.TW), a prominent diversified holding company that serves as a major institutional investor and maintains significant influence over the Board of Directors. This partnership provides DV Biomed with robust capital backing and governance oversight, supporting its ongoing expansion into the broader Asian healthcare and regenerative medicine markets.